Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) FCF Margin (2016 - 2025)

Regenxbio has reported FCF Margin over the past 12 years, most recently at 169.01% for Q4 2025.

  • Quarterly results put FCF Margin at 169.01% for Q4 2025, down 1485.0% from a year ago — trailing twelve months through Dec 2025 was 73.25% (up 13743.0% YoY), and the annual figure for FY2025 was 73.25%, up 13743.0%.
  • FCF Margin for Q4 2025 was 169.01% at Regenxbio, up from 189.86% in the prior quarter.
  • Over the last five years, FCF Margin for RGNX hit a ceiling of 82.0% in Q4 2021 and a floor of 447.99% in Q1 2023.
  • Median FCF Margin over the past 5 years was 202.54% (2021), compared with a mean of 207.21%.
  • Biggest five-year swings in FCF Margin: plummeted -22506bps in 2022 and later soared 39518bps in 2025.
  • Regenxbio's FCF Margin stood at 82.0% in 2021, then crashed by -274bps to 143.06% in 2022, then plummeted by -32bps to 188.57% in 2023, then increased by 18bps to 154.16% in 2024, then fell by -10bps to 169.01% in 2025.
  • The last three reported values for FCF Margin were 169.01% (Q4 2025), 189.86% (Q3 2025), and 232.84% (Q2 2025) per Business Quant data.